Mar 12, 2020
Non-Opioid Pain Relief Progress Showing Impressive Growth Rate Opportunities
Feb 26, 2020
Five Companies Transforming the Future of Breast Cancer Care
Dec 10, 2019
Small Molecule Oncology Drug Market Forecast to Exceed $66 Billion in 2019
Nov 26, 2019
How FDA and Oncology Industry are Making Joint Efforts to Utilize Accelerated Approval Pathways for Cancer Drugs
Oct 29, 2019
Market Share in Nanotechnology and Nanomedicine for Treatment of Viral Infections Could Reach Tens of Billion Dollars
Oct 22, 2019
Clinical Trials for Acute Myeloid Leukemia (AML) Drug Therapy Advancing With Encouraging Results
Aug 16, 2019
With Over USD 4 Billion in Capital Investment, the Synthetic Lethality-based Drugs Market is Poised to Witness a Rapid Growth, Claims Roots Analysis
Jun 04, 2019
Ovarian Cancer Disease Coverage Forecast and Market Analysis to 2023
Feb 19, 2019
Alkermes and Clovis Oncology Initiate Research Collaboration to Explore Combination Cancer Therapies
Feb 07, 2019
Paramount Developments Crucial for Advancing Clinical Trials Targeting Cancer Treatments
Jan 25, 2019
Global PARP Inhibitors in Oncology Research Report 2018: Background, Mechanism of Action, and Clinical Development of PARP Inhibitors
Dec 06, 2018
Stimulated Development of Orphan Drug Designations for Rare Diseases and Anti-Cancer Drug Candidates Intensifies
Dec 04, 2018
Explosion of Latest Clinical Studies and Results Reinvigorating Immunotherapy Market
Nov 15, 2018
Key Pancreatic Cancer Therapy Developments Crucial in Combating World's Toughest Cancer
Aug 09, 2018
Sierra Oncology Reports Second Quarter Results
Dec 28, 2017
Quotidian Technical Highlights on Selected Biotech Stocks -- Clovis Oncology, Exelixis, Celgene, and BioCryst Pharma
Oct 25, 2017
Sierra Oncology Appoints Dr. Andrew Allen to its Board of Directors